George Renaudin II - Sep 1, 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
President, Medicare & Medicaid
Signature
George Renaudin II
Stock symbol
HUM
Transactions as of
Sep 1, 2024
Transactions value $
-$106,698
Form type
4
Date filed
9/4/2024, 10:22 AM
Previous filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Options Exercise $0 +1.24K +12.9% $0.00 10.9K Sep 1, 2024 Direct F9
transaction HUM Humana Common Tax liability -$107K -303 -2.79% $352.14 10.6K Sep 1, 2024 Direct F11
holding HUM Humana Common 496 Sep 1, 2024 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Options Exercise $0 -1.24K -100% $0.00 0 Sep 1, 2024 Humana Common 1.24K Direct F4, F5
holding HUM Options 4.16K Sep 1, 2024 Humana Common 4.16K $510.24 Direct F2
holding HUM Options 6.97K Sep 1, 2024 Humana Common 6.97K $367.21 Direct F3
holding HUM Restricted Stock Units 230 Sep 1, 2024 Humana Common 230 Direct F4, F6
holding HUM Restricted Stock Units 609 Sep 1, 2024 Humana Common 609 Direct F4, F7
holding HUM Restricted Stock Units 719 Sep 1, 2024 Humana Common 719 Direct F4, F8
holding HUM Phantom Stock Units 163 Sep 1, 2024 Humana Common 163 See Footnote F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held for the benefit of reporting person as of August 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F4 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F5 Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.
F6 Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7 Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.
F8 Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F9 Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F10 Phantom Stock Units held for the benefit of reporting person as of August 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.
F11 Shares disposed of represent payment for tax liability for Restricted Stock vesting occurring on 9/1/24.